Embark on a journey through the intricate world of biologics developability and formulation assessment, where the fusion of science and strategy paves the way for groundbreaking advancements. Join our upcoming webinar to delve into a real-world case study that unravels the transformative power of key techniques, showcasing how a systematic, data-driven approach can revolutionize decision-making processes in biopharmaceutical development.
Unravel the complexities of biologic therapeutics with a cutting-edge, data-centric methodology that promises to redefine the landscape of formulation assessment. This innovative workflow aims to expedite the identification of risks in the early stages of development and enhance the progress of candidates across the development continuum. Through a compelling case study featuring a monoclonal antibody, witness firsthand the application and significance of pivotal techniques such as in silico profiling of colloidal and conformational stability, forced degradation studies, and formulation screening utilizing design of experiments (DoE). The seamless integration of predictive stability modeling and empirical stress testing across a spectrum of excipient systems underscores the resilience and efficacy of this approach.
Meet John Rockwell, the visionary Manager of BioAnalytics at Catalent, a trailblazer in the realm of biologics analytical sciences. With a Bachelor of Science degree in Biochemistry from Rutgers University and nearly two decades of unwavering dedication to analytical characterization and formulation development for biologics, John epitomizes strategic and technical excellence in advancing biologics developability and pre-formulation strategies. Join us as John shares his wealth of experience and insights to illuminate the path towards optimized biologics development.
Seize the opportunity to stay ahead of the curve by registering for our enlightening webinar. Explore the frontiers of pharmaceutical manufacturing and compliance, and equip yourself with the knowledge to drive innovation and progress in the dynamic world of biopharmaceuticals.
Key Takeaways:
– Embrace a data-driven approach to revolutionize biologics formulation assessment.
– Gain insights from real-world case studies to navigate the complexities of biologic therapeutics development.
– Learn how predictive stability modeling can enhance formulation screening and development efficiency.
Tags: formulation, automation
Read more on pharmtech.com